A股2月收官！沪指月线斩获3连阳，春节后市场交投持续活跃，"日成交超万亿"已成常态。从板块来看，热点聚焦度显著提升，涨价题材大放异彩，化工、 有色金属表现突出。 2月最后一个交易日（2月27日），A股三大指数涨跌不一，全市场超3200只个股上涨，沪深京三市成交额2.51万亿元，较昨日小幅缩量504亿元。 盘面上，小金属狂飙突进，稀土持续涨价，湖南黄金等9股狂掀涨停潮，有色ETF（159876）场内涨幅最高上探3.82%。磷化工风口叠加TDI行情催化，化工 ETF（516020）斩获4连阳，继续刷新2022年1月以来的阶段高点。 算力方向继续活跃！中国AI调用量首超美国，国产算力有望受益，重点布局国产AI产业链的科创人工智能ETF（589520）场内价格拉升2.03%；云计算进入 密集涨价周期，大数据ETF（516700）场内价格劲涨2.05%；华为云码道公测，盘古生态再扩容，重仓软件开发行业的信创ETF基金（562030）场内价格上 涨1.76%，收复5日、10日均线。 全球AI发展驱动电力需求激增，叠加"HALO交易"加持，电力ETF（159146）场内再涨2.64%连创上市新高，基金经理曹旭辰指出，伴随A ...

化工ETF（516020）及其联接基金（012537）跟踪中证细分化工产业主题指数，成份股覆盖AI算 力、反内卷、机器人、新能源等热门主题。其中近5成仓位集中于大市值龙头股，包括万华化学、盐湖 股份等，分享强者恒强投资机遇；其余5成仓位兼顾布局磷肥及磷化工、氟化工、氮肥等细分领域龙头 股，全面把握化工板块投资机会。 每日经济新闻 （责任编辑：董萍萍 ） 【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容 的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱： news_center@staff.hexun.com 进入马年，A股行情持续火热，2月25日，A股主要指数继续走强，化工行情再度刷新本轮反弹新 高。热门ETF品种——化工ETF（516020）早盘小幅高开后强势走高，场内价格涨逾2.8%。最近6个交 易日，超2亿元资金持续净流入化工ETF（516020），积极布局节后行情。 广发证券指出，化工作为典型周期性行业，通常5年一轮周期，经历"盈利上行-产能扩张-盈利触底- 产能出清/需求预期改善"四个阶段。伴随资本开支 ...

化工ETF（516020）及其联接基金（012537）跟踪中证细分化工产业主题指数，成份股覆盖AI算力、反 内卷、机器人、新能源等热门主题。其中近5成仓位集中于大市值龙头股，包括万华化学、盐湖股份 等，分享强者恒强投资机遇；其余五成仓位兼顾布局磷肥及磷化工、氟化工、氮肥等细分领域龙头股， 全面把握化工板块投资机会。 2月24日，春节后的第一个交易日，A股三大指数均大幅高开，化工板块延续节前的反弹趋势，早盘大 幅高开。热门ETF品种——化工ETF（516020）早盘高开高走，场内价格涨逾2.7%。最近5个交易日， 超2.2亿元资金持续净流入化工ETF（516020），积极布局节后行情。 广发证券指出，化工作为典型周期性行业，通常5年一轮周期，经历"盈利上行—产能扩张—盈利触底— 产能出清/需求预期改善"四个阶段。伴随资本开支增速转负、反内卷、海外降息、扩内需，看好"十五 五"开局阶段化工"破晓时分"。此外，全球技术革命持续提速，材料变革迎新机遇。 国海证券指出，反内卷有望重估中国化工行业，后续措施有望使全球化工行业产能扩张大幅放缓。中国 化工行业具有充沛的经营活动现金流净额，一旦扩张放缓，潜在股息率将大幅提升， ...

化工板块今日（2月11日）继续猛攻！反映化工板块整体走势的化工ETF（516020）开盘后直线拉升， 盘中场内价格涨幅一度达到3.02%，而后持续高位震荡，截至收盘，涨2.19%。 成份股方面，锂电、石化、钛白粉等板块部分个股涨幅居前。截至收盘，新宙邦飙涨8.16%，桐昆股份 大涨7.82%，新凤鸣、恩捷股份、龙佰集团等亦涨幅居前。 | | | 分时 部日 1分 5分 15分 30分 60分 日 周 月 霞多 | | | | | | F9 盘萌像层 露加 九线 面线 工具 @ (2) > | | | 化工ETF (D | | 516020 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 0.00 | | | | 516020(RZIFF) 14:21 拾 0.962 盈跌 0.021(2.19%) 均价 0.979 股交量 149 IOPV 0.9826 | | | | | 2026/02/11 | | 0.982 | | +0.021 +2.199 | | | | | | wa ...

Group 1 - The A-share market showed mixed performance on February 11, with the chemical sector rebounding after a brief correction, supported by over 740 million yuan of net inflow into the chemical ETF (516020) during the last 10 trading days [1] - According to GF Securities, the chemical industry typically follows a five-year cycle characterized by phases of "profit upturn - capacity expansion - profit bottoming - capacity clearance/demand expectation improvement," and the current environment is favorable for the chemical sector as capital expenditure growth turns negative and domestic demand expands [1] - Guohai Securities suggests that the trend of reducing competition in the chemical industry may lead to a significant slowdown in global capacity expansion, which could enhance the potential dividend yield for Chinese chemical companies, transforming them from cash-consuming entities to cash-generating ones [1] Group 2 - The chemical ETF (516020) and its linked fund (012537) track the CSI segmented chemical industry theme index, with nearly 50% of its holdings concentrated in large-cap leading stocks such as Wanhua Chemical and Salt Lake Industry, while the other 50% covers leading stocks in sub-sectors like phosphate fertilizers, fluorochemicals, and nitrogen fertilizers [2]

Group 1 - The chemical sector is experiencing a rebound, with the chemical ETF (516020) showing a significant increase of 1.77% as of the report, peaking at a 1.98% rise during the trading session [1][2] - Key stocks in the sector include New Chemical Materials, which surged over 8%, and other notable gainers such as New Fengming, Rongsheng Petrochemical, and Tongkun Co., all showing increases of over 4% [1][2] - Recent reports from major foreign investment firms, including UBS and Morgan Stanley, have upgraded their outlook on the Chinese chemical industry, predicting a new upward cycle from 2026 to 2028 due to multiple positive factors [1][3] Group 2 - Guohai Securities suggests that the re-evaluation of the Chinese chemical industry could lead to a significant slowdown in global capacity expansion, potentially transforming the industry from a cash-consuming entity to a cash-generating one [3] - The chemical ETF (516020) tracks the CSI sub-sector chemical industry index, covering popular themes such as AI computing power, de-involution, robotics, and new energy [3]

Group 1 - The chemical sector continues to rebound, with the Chemical ETF (516020) showing a maximum intraday increase of 1.98% and a current increase of 1.77% as of the report [1][7] - Key stocks in the petrochemical and lithium battery sectors have seen significant gains, with New Zhou Bang rising over 8%, Xin Feng Ming increasing over 5%, and several others like Rongsheng Petrochemical and Tongkun Co. rising over 4% [1][7] - Recent reports from major foreign investment firms, including UBS and Morgan Stanley, are optimistic about the Chinese chemical industry, predicting a new upward cycle from 2026 to 2028 due to multiple positive factors [1][9] Group 2 - Guohai Securities suggests that the re-evaluation of the Chinese chemical industry could lead to a significant slowdown in global chemical capacity expansion, enhancing potential dividend yields and transforming the industry from a cash-consuming entity to a cash-generating one [3][9] - The Chemical ETF (516020) tracks the CSI sub-sector chemical industry theme index, covering popular themes such as AI computing power, anti-involution, robotics, and new energy, making it an efficient way to invest in the sector [3][9]

Group 1 - The chemical sector continues to rebound, with the Chemical ETF (516020) opening high and experiencing a maximum intraday increase of 1.79%, closing with a gain of 1.48% [1][7] - Key stocks in the sector include Zhejiang Longsheng, which surged by 9.5%, and Tongcheng New Materials, which rose by 4.86%, along with several others exceeding 3% gains [1][7] - The Chemical ETF tracks a specialized index that includes popular stocks in sectors like new energy, which are expected to benefit significantly from the ongoing growth in electric vehicle sales [9][10] Group 2 - According to Zhongyuan Securities, the ongoing anti-involution policies are expected to strengthen supply-side constraints in the industry, benefiting certain sub-sectors such as chlor-alkali, pesticides, and polyester filament [10] - Guohai Securities notes that the anti-involution measures may lead to a revaluation of the Chinese chemical industry, with potential for increased cash flow and dividend yields as capacity expansion slows [10] - The Chemical ETF (516020) is suggested as an efficient way to capitalize on the rebound in the chemical sector, covering themes like AI computing power and new energy [10][11] Group 3 - Recent data from the Ministry of Commerce indicates that as of February 5, 2026, there were 335,000 applications for the vehicle trade-in subsidy, driving new car sales to 53.77 billion yuan, which supports market development and resource recycling [8][9] - The average price of new cars participating in the trade-in program exceeded 160,000 yuan, showing a significant increase compared to the previous year, while the number of scrapped vehicles reached 659,000, a year-on-year increase of 50.2% [8][9]

化工板块周五（2月6日）逆市猛攻。反映化工板块整体走势的化工ETF（516020）早盘低开后迅速拉 升，盘中场内价格最高涨幅达到3.45%，而后持续高位震荡，尾盘略有回落，最终逆市收涨2.37%。 成份股方面，锂电、磷化工、石化等板块部分个股涨幅居前。截至收盘，恩捷股份涨停，宏达股份、浙 江龙盛、天赐材料等大涨超6%，恒逸石化、荣盛石化、华峰化学等亦涨幅居前。 | | | | 分时 多日 1分 5分 15分 30分 60分 日 周 月 图8 | | | | | F9 盘前盘后 露加 九特 画球 工具 @ (2) > | | 44. TETF O | | 516020 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | DOG | | | | 516020Hz工ETF] 15:00 � 0.949 通款 0.022(2.37%) 均价 0.947 服交量 0.10PV 0.9491 | | | | | 2026/02/06 | 0 946 | | +0.022 +2.379 | | | | | | ...

Market Overview - A-shares experienced volatility on February 6, with the Shanghai Composite Index closing down 0.25% at 4065.58 points, and the ChiNext Index down 0.73% [1] - The overall market turnover decreased to 2.16 trillion yuan, marking a continuous six-day decline in trading volume [1] Sector Performance - The chemical and new energy sectors led the market, while the pharmaceutical sector showed relative resilience. Consumer goods experienced a pullback, and technology continued to be sluggish [1] - The chemical ETF (516020) saw a significant inflow of 199 billion yuan, with a daily gain of 2.37% after reaching a peak increase of 3.45% during the day [2][5][6][8] Chemical Sector Insights - The chemical sector is experiencing a strong upward cycle, driven by increased demand for lithium batteries and key chemical materials [9][10] - Major stocks in the chemical sector, such as Enjie Co., Ltd. and Zhejiang Longsheng, saw significant gains, with some stocks rising over 6% [6][9] Non-Ferrous Metals Sector - The non-ferrous metals sector demonstrated resilience, with the non-ferrous ETF (159876) reversing early losses to close slightly up by 0.18% despite fluctuations in international gold prices [3][11] - Over 100 billion yuan of main funds flowed into the non-ferrous metals sector, indicating strong investor interest [11] Hong Kong Market Dynamics - The Hong Kong market experienced a downward trend, with the Hang Seng Index and Hang Seng Tech Index both closing down over 1% [3] - Despite the overall decline, there was significant buying activity from southbound funds, with purchases reaching 133.7 billion HKD, 249.8 billion HKD, and 148.6 billion HKD over three days [4] Pharmaceutical Sector Developments - The Hong Kong pharmaceutical sector showed signs of recovery, with the innovative drug ETF (520880) rising by 2% during the day, driven by strong earnings forecasts from key companies [15][16] - Notable performers included Innovent Biologics, which projected a revenue increase of approximately 134% by 2025, and several other companies expecting significant profit growth [16][18] Investment Opportunities - Analysts suggest that the chemical sector remains a promising investment opportunity, particularly in leading companies and price recovery products [10][22] - For investors looking to capitalize on the pharmaceutical sector, the innovative drug ETF (520880) and the medical ETF (159137) are recommended for their strong growth potential and coverage of key industry players [21][22]